pfizer

Pfizer Standalone September 2019 Net Sales at Rs 567.06 crore, up 9.1% Y-o-Y

Market Headstart: Nifty seen opening higher; Kansai Nerolac Paints, Jyothy Labs top buys

Trends on SGX Nifty indicate a positive opening for the broader index in India, with an 11 points gain, or 0.09 percent

Looking for momentum play? Dabur, Pfizer among top 5 stocks which can return 10-15%

A break below 10,637 levels will indicate a resumption of the downtrend in the market.

Pfizer Q1 net up 23% at Rs 113 crore

The company had posted a profit of Rs 91.84 crore in the same quarter last fiscal, Pfizer said in a regulatory filing.

Pfizer Standalone June 2019 Net Sales at Rs 544.40 crore, up 6.26% Y-o-Y

Corporate Corridor | Pfizer’s Upjohn and Mylan combining forces holds lessons for Indian pharma majors

The merger of Pfizer’s Upjohn division and Mylan may not only attempt to solve their problems in the US market but also make inroads into emerging markets, particularly China

Why revolving door at USFDA raises ethical concerns?

A revolving door is a practice where people in highly influential positions in the government move to jobs in the private sector and vice-versa.

Pfizer bolsters cancer portfolio with $10.64 billion deal for Array

The company has also been pushing its '15 in 5' plan to launch 15 experimental treatments, each with at least $1 billion annual sales potential, over a five-year period and has been investing in cancer drugs and gene therapies.

Pfizer Standalone March 2019 Net Sales at Rs 535.66 crore, up 3.02% Y-o-Y

Pfizer Q4 net up 4.74% to Rs 109.47 cr

Revenue from operations for the March quarter stood at Rs 535.66 crore. It was at Rs 519.95 crore for the year-ago period.

Pfizer Standalone December 2018 Net Sales at Rs 513.79 crore, up 12.54% Y-o-Y

Pfizer Q3 net profit at Rs 131.94 crore

Pfizer's total income was Rs 578.14 crore during the quarter under review. It was Rs 488.62 crore in the corresponding quarter a year ago.

Market Headstart: Nifty likely to see gap-up opening; 3 stocks which could give 9-12% return

A gap-up opening is likely as Nifty Futures on Singaporean Exchange were trading over 70 points higher. The futures traded around 10,908-odd levels.

Pfizer to shutdown Chennai, Aurangabad plants, may impact 1700 employees

Both plants came under Pfizer's ownership after it acquired Hospira in the US.

GSK, Pfizer to merge consumer healthcare units

GSK said it would have a 68-percent controlling equity interest in the GSK Consumer Healthcare joint venture that will have combined sales of about 9.8 billion pounds ($12.7 billion, 10.9 billion euros).

GSK to split after striking Pfizer consumer health deal

The revamp is the boldest move yet by GSK Chief Executive Emma Walmsley, who took over last year.

Pfizer Standalone September 2018 Net Sales at Rs 519.74 crore, down 8.99% Y-o-Y

Pfizer Q2 net profit falls 14% to Rs 95.8 crore

The company had posted a net profit of Rs 111.15 crore for the corresponding period of the previous fiscal.

Podcast | Stock picks of the day: Top 3 stocks which could give 6-11% return in next 1 month

The only saving grace is 10,200 rising trendline support zone on the weekly chart which the Nifty has just managed to hold above.

Buy Pfizer; target of Rs 3100: Centrum

Centrum recommended hold rating on Pfizer with a target price of Rs 3100 in its research report dated September 10, 2018.

International Paper, Mahindra Logistics, Pfizer gain 5-9% after June quarter earnings

International Paper APPM, Mahindra Logistics and Pfizer reported strong set of earnings for the quarter ended June 2018.

Pfizer Q1 net profit up 61% to Rs 92 cr

Standalone revenue from operations of the company stood at Rs 512.31 crore for the April-June quarter of the current fiscal. It was Rs 432.59 crore for the year-ago period.

Pfizer delays drug price hikes after talking with Donald Trump

The rollback came a day after Trump took aim at Pfizer and other U.S. drugmakers for raising prices on some of their medicines, saying in a tweet that they "should be ashamed" and that his administration would respond.

Profit booking likely on D-St; Top 3 stocks which could give over 10% return

At this juncture, markets are clearly experiencing their corrective phases (price wise as well as time-wise) and hence, one should not venture into it aggressively.

Markets@Moneycontrol: Nifty likely to open higher; 3 stocks which could give 17-19% return

Trends on SGX Nifty indicate a positive opening for the broader index in India, a rise of 25 points or 0.24 percent. Nifty futures were trading around 10,656-level on the Singaporean Exchange.